CELA2A mutations predispose to early-onset atherosclerosis and metabolic syndrome and affect plasma insulin and platelet activation
暂无分享,去创建一个
S. Mane | R. Lifton | R. Kibbey | A. Mani | A. Szabó | M. Sahin-Tóth | J. Bender | M. Nathanson | F. Gorelick | R. Cardone | J. Hwa | Mateus T. Guerra | G. Kayingo | Mohsen Fathzadeh | Renata Belfort-DeAguiar | Adebowale J. Adeniran | Sunny Chung | Tarun Tyagi | Fatemehsadat Esteghamat | Bani M Azari | N. Ugwu | J. S. Broughton | Mitra V Mani | Emily Smith | Ephraim N. Weiss | Rebecca L. Cardone
[1] P. O’Reilly,et al. Correction: Corrigendum: Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk , 2017, Nature Genetics.
[2] Andrew D. Johnson,et al. Novel Blood Pressure Locus and Gene Discovery Using Genome-Wide Association Study and Expression Data Sets From Blood and the Kidney , 2017, Hypertension.
[3] R. Mains,et al. Brain Region and Isoform-Specific Phosphorylation Alters Kalirin SH2 Domain Interaction Sites and Calpain Sensitivity. , 2017, ACS chemical neuroscience.
[4] N. Risch,et al. Genome-wide association analyses using electronic health records identify new loci influencing blood pressure variation , 2016, Nature Genetics.
[5] A. Szabó,et al. Complex Formation of Human Proelastases with Procarboxypeptidases A1 and A2* , 2016, The Journal of Biological Chemistry.
[6] Yu Jin,et al. Inducing mitophagy in diabetic platelets protects against severe oxidative stress , 2016, EMBO molecular medicine.
[7] Y. Hong,et al. Associations of Sarcopenia and Sarcopenic Obesity With Metabolic Syndrome Considering Both Muscle Mass and Muscle Strength , 2015, Journal of preventive medicine and public health = Yebang Uihakhoe chi.
[8] R. Colbran,et al. Quantitative proteomics analysis of CaMKII phosphorylation and the CaMKII interactome in the mouse forebrain. , 2015, ACS chemical neuroscience.
[9] R. Malekzadeh,et al. A form of the metabolic syndrome associated with mutations in DYRK1B. , 2014, The New England journal of medicine.
[10] G. Go,et al. The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescue. , 2014, Cell metabolism.
[11] C. Östenson,et al. The Type 2 Diabetes–Associated Gene Ide Is Required for Insulin Secretion and Suppression of α-Synuclein Levels in β-Cells , 2013, Diabetes.
[12] J. Holst,et al. Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies , 2013, Diabetologia.
[13] N. Stefan,et al. Impairment of GLP1‐induced insulin secretion: role of genetic background, insulin resistance and hyperglycaemia , 2012, Diabetes, obesity & metabolism.
[14] J. Olefsky,et al. Neutrophils mediate insulin resistance in high fat diet fed mice via secreted elastase , 2012, Nature Medicine.
[15] A. Clark,et al. Recent Explosive Human Population Growth Has Resulted in an Excess of Rare Genetic Variants , 2012, Science.
[16] Dennis C. Sgroi,et al. Gene Expression Profiles of Beta-Cell Enriched Tissue Obtained by Laser Capture Microdissection from Subjects with Type 2 Diabetes , 2010, PloS one.
[17] Deng-Chyang Wu,et al. P-selectin-dependent platelet aggregation and apoptosis may explain the decrease in platelet count during Helicobacter pylori infection. , 2010, Blood.
[18] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[19] G. Lowe,et al. Relative Value of Inflammatory, Hemostatic, and Rheological Factors for Incident Myocardial Infarction and Stroke: The Edinburgh Artery Study , 2007, Circulation.
[20] Jayaram Radhakrishnan,et al. LRP6 Mutation in a Family with Early Coronary Disease and Metabolic Risk Factors , 2007, Science.
[21] E. Szepessy,et al. Inactivity of Recombinant ELA2B Provides a New Example of Evolutionary Elastase Silencing in Humans , 2006, Pancreatology.
[22] W. Catterall,et al. Sites of proteolytic processing and noncovalent association of the distal C-terminal domain of CaV1.1 channels in skeletal muscle. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[23] Nathan D. Wong,et al. Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults , 2004, Circulation.
[24] Guohong Liu,et al. Cav1.3 is preferentially coupled to glucose-induced [Ca2+]i oscillations in the pancreatic beta cell line INS-1. , 2004, Molecular pharmacology.
[25] J. Weissenbach,et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia , 2003, Nature Genetics.
[26] Matthew P. Frosch,et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[27] C. Bogardus,et al. Microarray profiling of skeletal muscle tissues from equally obese, non-diabetic insulin-sensitive and insulin-resistant Pima Indians , 2002, Diabetologia.
[28] R. Wu,et al. The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice , 2002, Diabetologia.
[29] P. Touboul,et al. Serum Elastase Activity, Serum Elastase Inhibitors, and Occurrence of Carotid Atherosclerotic Plaques: The Etude sur le Vieillissement Artériel (EVA) Study , 2002, Circulation.
[30] Y. Kido,et al. CEACAM1 regulates insulin clearance in liver , 2002, Nature Genetics.
[31] M. Bünemann,et al. C-terminal Fragments of the α1C(CaV1.2) Subunit Associate with and Regulate L-type Calcium Channels Containing C-terminal-truncated α1CSubunits* , 2001, The Journal of Biological Chemistry.
[32] W. Kohrt,et al. Effect of aging. , 2000, Nutrition reviews.
[33] Alan D. Lopez,et al. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study , 1997, The Lancet.
[34] C. Daly,et al. Post-Transcriptional Regulation of Synaptic Vesicle Protein Expression and the Developmental Control of Synaptic Vesicle Formation , 1997, The Journal of Neuroscience.
[35] M. Horie,et al. Increased calcium-channel currents of pancreatic beta cells in neonatally streptozocin-induced diabetic rats. , 1994, Metabolism: clinical and experimental.
[36] P. Frey,et al. A low-barrier hydrogen bond in the catalytic triad of serine proteases. , 1994, Science.
[37] L. Berkman,et al. Genetic susceptibility to death from coronary heart disease in a study of twins. , 1994, The New England journal of medicine.
[38] M. Jacob,et al. Cell‐Matrix Interactions in the Genesis of Arteriosclerosis and Atheroma , 1992, Annals of the New York Academy of Sciences.
[39] A. Frelinger,et al. Activation of the fibrinogen receptor on human platelets exposed to alpha chymotrypsin. Relationship with a major proteolytic cleavage at the carboxyterminus of the membrane glycoprotein IIb heavy chain. , 1991, European journal of biochemistry.
[40] A. Mitra,et al. Degradation of Insulin by Trypsin and Alpha-Chymotrypsin , 1991, Pharmaceutical Research.
[41] J. Powers,et al. Irreversible inhibition of serine proteases by peptide derivatives of (alpha-aminoalkyl)phosphonate diphenyl esters. , 1991, Biochemistry.
[42] R M Stroud,et al. The three-dimensional structure of Asn102 mutant of trypsin: role of Asp102 in serine protease catalysis. , 1988, Science.
[43] J. Hoxie,et al. Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. , 1985, The Journal of biological chemistry.
[44] C. Largman,et al. Purification and characterization of two human pancreatic elastases. , 1976, Biochemistry.
[45] A. Fersht,et al. The charge relay system in chymotrypsin and chymotrypsinogen. , 1973, Journal of molecular biology.
[46] D. Selkoe,et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[47] Alan D. Lopez,et al. The Global Burden of Disease Study , 2003 .
[48] M. Bunemann,et al. C-terminal fragments of the alpha 1C (CaV1.2) subunit associate with and regulate L-type calcium channels containing C-terminal-truncated alpha 1C subunits. , 2001, The Journal of biological chemistry.
[49] T. Iwamoto,et al. Anti-atherosclerotic action of elastase--with special reference to its effect on elastic fibres. , 1983, Age and ageing.